Scope of Lymphadenectomy Not Tied to Esophageal CA Survival

This article originally appeared here.
Share this content:
Scope of Lymphadenectomy Not Tied to Esophageal CA Survival
Scope of Lymphadenectomy Not Tied to Esophageal CA Survival

FRIDAY, Sept. 4, 2015 (HealthDay News) -- For patients undergoing esophageal cancer surgery, the extent of lymphadenectomy seems not to influence all-cause or disease-specific survival, according to a study published online Sept. 2 in JAMA Surgery.

Jesper Lagergren, M.D., Ph.D., from the Guy's and St. Thomas' NHS Foundation Trust in London, and colleagues examined data from a cohort of patients who underwent esophagectomy for cancer in 2000 to 2012 at a high-volume hospital, with follow-up until 2014.

The researchers found that 83.5 percent of the 606 included patients had adenocarcinoma of the esophagus. Fifty-three percent of participants died within five years of surgery and 39 percent died of tumor recurrence. There was no significant association between the extent of lymphadenectomy and all-cause or disease-specific mortality, irrespective of the categorization of lymphadenectomy or stratification for T category, calendar period, or chemotherapy. There was no significant reduction in all-cause five-year mortality for patients in the fourth versus the lowest quartile of the number of removed nodes (21 to 52 versus 0 to 10 nodes; hazard ratio, 0.86; 95 percent confidence interval, 0.63 to 1.17), particularly not in the most recent calendar period (hazard ratio, 0.98; 95 percent confidence interval, 0.57 to 1.66) for years 2007 to 2012.

"This study indicated that the extent of lymphadenectomy during surgery for esophageal cancer might not influence five-year all-cause or disease-specific survival," the authors write. "These results challenge current clinical guidelines."

Abstract
Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Rising Fatal Drug Overdoses Linked to Years of Life Lost

Rising Fatal Drug Overdoses Linked to Years of ...

Growth in fatal overdoses linked to increased mortality, years of life lost for non-Hispanic whites

Atherosclerotic CVD Mortality Higher in South Asians in the U.S.

Atherosclerotic CVD Mortality Higher in South Asians in ...

Most of the increased risk can be attributed to increased prevalence of known risk factors

Global Variation in Personal Health Care Access and Quality

Global Variation in Personal Health Care Access and ...

Highest performance in Iceland, lowest in Central African Republic, with variation in rate of progress